Okonda Sylvain, Wright Colleen, Michelow Pam
Central Public Health Laboratory, Ministry of Health and Social Welfare, Swaziland.
Cytojournal. 2009 Aug 6;6:14. doi: 10.4103/1742-6413.54916.
Cancer of the cervix is the most common cancer in women in Swaziland where most women never undergo cervical screening. The extremely high prevalence of HIV/AIDS in Swaziland complicates the management of preinvasive and invasive cervical cancer. The purpose of this study was to assess the current status of cervical cytology in Swaziland, its strengths and limitations.
The study is a retrospective review of 12,188 conventional cervical smears received by the Central Public Health Laboratory in Swaziland from June 2004 to May 2006.
Review of results showed very high rates of cytologic abnormalities with 43.2% of smears screened reported as abnormal. The percentages of abnormalities were as follows: atypical squamous cells of undermined significance (ASC-US), 19.8%; atypical squamous cells, cannot exclude HSILs (ASC-H), 8.8%; low-grade squamous intraepithelial lesions (LSIL), 9.0%; high-grade squamous intraepithelial lesions (HSIL), 4.6%; squamous cell carcinomas, 0.5%; atypical endocervical cells, 0.6%; and atypical endometrial cells, 0.4%. Just over 5% of smears were inadequate. The highest rates of HSILs and invasive squamous carcinoma occurred in women aged 50-59 years.
This study underscores the need to reduce the incidence of cervical cancer and its precursor lesions in Swaziland women. Based on studies of human papillomavirus (HPV) types in other Southern African countries, current HPV vaccines would reduce the incidence and mortality from cervical cancer in the future, but cervical screening would still be required, both for women already infected with the HPV and for HPV subtypes not covered by current vaccines. The most cost-effective combination of screening modalities such as visual inspection, HPV DNA testing, and cytology should be investigated. Cervical cancer reduction needs to be managed within the greater framework of the HIV/AIDS epidemic.
宫颈癌是斯威士兰女性中最常见的癌症,该国大多数女性从未接受过宫颈筛查。斯威士兰极高的艾滋病毒/艾滋病患病率使宫颈原位癌和浸润性宫颈癌的管理变得复杂。本研究的目的是评估斯威士兰宫颈细胞学的现状、优势及局限性。
该研究是对斯威士兰中央公共卫生实验室在2004年6月至2006年5月期间收到的12188份传统宫颈涂片进行的回顾性分析。
结果回顾显示细胞学异常率非常高,43.2%的筛查涂片报告为异常。异常百分比分别如下:意义不明确的非典型鳞状细胞(ASC-US),19.8%;非典型鳞状细胞,不能排除高级别鳞状上皮内病变(ASC-H),8.8%;低级别鳞状上皮内病变(LSIL),9.0%;高级别鳞状上皮内病变(HSIL),4.6%;鳞状细胞癌,0.5%;非典型宫颈管细胞,0.6%;非典型子宫内膜细胞,0.4%。略超过5%的涂片不合格。HSIL和浸润性鳞状癌的最高发病率出现在50 - 59岁的女性中。
本研究强调了降低斯威士兰女性宫颈癌及其前驱病变发病率的必要性。基于其他南部非洲国家对人乳头瘤病毒(HPV)类型的研究,目前的HPV疫苗未来将降低宫颈癌的发病率和死亡率,但仍需要进行宫颈筛查,这对于已经感染HPV的女性以及目前疫苗未涵盖的HPV亚型女性均适用。应研究诸如肉眼检查、HPV DNA检测和细胞学检查等筛查方式最具成本效益的组合。宫颈癌的防治需要在艾滋病毒/艾滋病流行这一更大的框架内进行管理。